Welcome to the conference call and webcast to discuss the combination of Olin Corporation and Huntsman Corporation. At this time, all participants have been placed in a listen-only mode, and the floor will be open for your questions following the presentation. If you would like to ask a question at that time, please press star one on your telephone keypad. If at any point your question has been answered, you may remove yourself from the queue by pressing star two. That others can hear your question clearly, we ask that you pick up your handset for best sound quality. Lastly, if you should require operator assistance, please press star zero. I would now like to turn the call over to Steve Keenan, Director of Investor Relations at Olin. Sir, please begin. Thanks, Chelsea, welcome everyone. I'm joined on the call today by Ken Lane, President and Chief Executive Officer of Olin, and Peter Huntsman, Chairman, President, and Chief Executive Officer of Huntsman. Todd Slater, Olin's Senior Vice President and Chief Financial Officer, and Phil Lister, Huntsman's Executive Vice President and Chief Financial Officer, will participate in the Q&A portion of today's call. Before we begin, I'd like to remind everyone that today's discussion regarding Olin and Huntsman includes forward-looking statements, including expectations regarding the proposed transaction. These statements are subject to risks and uncertainties. We encourage you to review our related SEC filings for more detail. I would now like to turn the call over to Ken. Thank you, Steve, good morning, everyone. I appreciate you joining us. Today is a momentous one for Olin and Huntsman, two storied American companies with a shared commitment to safety, integrity, operational excellence, and serving customers around the world, all while creating value for our shareholders. The all-stock merger of equals we announced this morning will create a greater than $12 billion chemicals leader with a strong North American anchor and complementary European and Asian portfolios. By integrating Olin's strong upstream manufacturing and feedstock position with Huntsman's differentiated downstream capabilities, we will have a world-scale, vertically integrated platform that is better positioned to serve customers and deliver resilient financial performance. The combined portfolio also creates tangible integration opportunities across key value chains, supporting a lower-cost position through the cycle. These strategic tailwinds are paired with more than $400 million of cost synergies and integration benefits. The combined business will have strong cash flow to support disciplined capital allocation, including near-term de-leveraging, returning capital to shareholders, and investing in high-return growth projects. I've spent my career in chemicals across both commodity and downstream businesses, including running a global polyurethanes business. I understand how to get the best out of these businesses. In many respects, that means running them as complementary but separate. I'm confident we can do that while also delivering on the benefits of this transaction. Olin's stated strategy is to focus on strengthening our core businesses, maximizing value, and expanding into higher-value applications where we can achieve attractive returns through innovation and operational improvements. This transaction hits those marks. Further, as Olin-Huntsman, we'll be led by a team with the right experience and shared foundational values to ensure we are capturing all the opportunities available to us. I'd now like to turn it over to Peter Huntsman to walk through the transaction structure and combined platform in greater detail. Before I do, I'll take a moment to recognize Olin's dedicated employees, whose commitment and focus has made today's milestone possible. I'm very proud to be part of the Olin team. I'd also like to acknowledge Peter and his team. As you might expect, over the course of reaching this agreement, Peter and I have spent a good deal of time together. It's been clear what a world-class team Huntsman also has with great expertise, and most importantly, truly held values that we at Olin share. Peter, I'm looking forward to working with you and the other directors of the board. I know OlinHuntsman is going to do great things. Ken, thank you very much. Good morning, everyone, and thank you for taking the time to join us. It is an honor to be here today, and I echo Ken's enthusiasm for the opportunities ahead. As our industry continues to globalize, we compete more today against countries than companies, trade policies, and global supply chains more than ever before. The opportunities this merger creates enables us to generate greater value for our shareholders, delivers exceptional services and products for our customers, and provide greater opportunities and stabilities for our associates. This merger of equals takes two great companies and creates a much stronger global leader. Let me provide some further detail. Let's turn to slide number five. We have structured this combination as an all-stock merger of equals, which we believe capitalizes on the strength of both companies and presents the best value creation opportunities for both sets of shareholders. Under the terms of the agreement, Huntsman shareholders will receive 0.5476 shares of Olin for each Huntsman share they own. Resulting in Olin shareholders owning approximately 54.5% and Huntsman shareholders owning approximately 45.5% of the combined company. The combined company will be named OlinHuntsman Corporation and will be headquartered in The Woodlands, Texas. As Ken mentioned, we have identified more than $400 million of cost synergies and integration benefits. Our respective teams have spent a great deal of time together identifying and validating these synergies, and Ken will provide greater detail on how we will achieve them later in this presentation. The transaction is expected to close in the first half of 2027, subject to receipt of regulatory approvals and satisfaction of other customary closing conditions, including approval from both Olin and Huntsman shareholders. Following the close, I will serve as non-exec chairman of the board of directors, and Ken will assume the role of Chief Executive Officer. Phil Lister will serve as Chief Financial Officer, and Todd Slater will serve as the Chief Integration Officer. Let's turn to slide number six. Let me spend a moment on the scale and benefits of the combined company. Using 2025 reported financials on a pro forma basis, the combined company would have generated approximately $12.5 billion in revenue and approximately $1.3 billion of adjusted EBITDA, including expected cost synergies. We will be anchored in cost-advantaged North American assets and feedstocks with integrated portfolios that create multiple channels for improved economics and value creation across a broad range of attractive end markets. We also have identified opportunities in Europe that capitalize on our integration and downstream capabilities. With Huntsman's relationships in these global end markets, we have a unique opportunity to deliver for our customers more profitably by leveraging Olin assets to improve efficiency across the value chain. We can turn to slide number seven. Our industry has changed a lot over the last five years. Cost position, reliability, and integration matters more than ever. That is why I believe this type of integration is essential to driving optionality and higher profitability now and into the future. You see on slide seven, Olin brings advantaged upstream leadership, including an efficient cost position from U.S. Gulf Coast economics and world-scale chemical assets. Huntsman brings downstream application expertise, including leading positions in MDI and polyurethane systems, amines, maleic anhydride, and advanced materials, supported by deep end-market customer relationships. Put simply, we believe this combination will drive value creation for our shareholders and unlock greater profitability. Looking at slide eight, there is a clear indication of how integration creates value for both companies across several key value chains. The combination brings together selected Olin and Huntsman capabilities across electrochemical units to polyurethanes, electrochemical units to amines, and to epoxies. Olin is strong at the front end of the value chain with the ability to make chlorine and caustic soda safely, reliably, and at world scale. Huntsman is strong downstream, particularly in polyurethanes, amines, advanced materials, and formulation-driven applications. By combining these capabilities, we create more reliability and better integrated supply chains capable of generating greater value to shareholders and customers. For example, today, Olin has several existing outlets for chlorine, including vinyls, epoxy, water treatment, chlorinated organics, merchant chlorine, and hydrochloric acid. Through the combination, OlinHuntsman will have additional outlets across polyurethanes, amines, and advanced materials, broadening participation across the value chain. It also creates a vertically integrated U.S. MDI producer. Starting in 2031, as current supply contracts expire, we expect to add an additional $100 million or more of incremental synergies. The result is a more closely integrated set of chlorine-linked value chains that benefits both businesses and positions the combined company for future downstream opportunities across high-growth end markets. Before turning our concluding comments back to Ken, I'd like to comment that from the first meeting nearly four months ago, we have both seen this as a merger of opportunities where the sum of the parts create greater benefits than both companies remaining separate. I have found in Ken a leader that shares a vision and the capability to create greater value and opportunity in this merger. Ken? Thank you, Peter. The expected cost synergies and integration benefits from this combination are significant and actionable. The companies have identified more than $400 million of value with clear line of sight. Of that, we see $300 million of synergies, with much of that achieved in the first 24 months following close. These synergies are expected to come from several areas, including purchasing and raw materials integration, optimization of operations, and SG&A savings. As we've said, we also expect to capture more value internally with more than $100 million of additional raw material integration benefits in 2031 due to expiring contracts and Olin stepping in to fill supply. We expect the cost to achieve these synergies to be approximately $150 million-$200 million. In addition, OlinHuntsman is expected to benefit from approximately $125 million of cash tax benefits from acceleration of tax NOLs, which is not included in the synergy figure. Both Olin and Huntsman have executed complex integrations before, including the Dow Chlorine Products business, where Olin delivered more synergies than originally announced, and Huntsman's track record of integrating multiple acquisitions of different sizes and complexity over the years. We'll bring that same discipline and accountability to this combination. OlinHuntsman is expected to have improved profitability and cash flow through the cycle. As we mentioned earlier, despite a challenging market backdrop on a 2025 pro forma basis, OlinHuntsman would have generated over $900 million of adjusted EBITDA. When including the expected synergies of $400 million, the combined company would have generated approximately $1.3 billion of adjusted EBITDA. Looking across the 2021 to 2025 period on a pro forma basis, OlinHuntsman would have generated approximately $2.7 billion of average adjusted EBITDA, including the $400 million of synergies. We believe this shows the capability of the combined company to deliver compelling profitability, substantial free cash flow, and importantly, greater resilience across varying operating environments. On the following slide, we provide some more detail on the pro forma financial profile of the business. We expect to have a healthy balance sheet with an evenly weighted maturity profile, no bond maturities before 2029, and an attractive blended cost of debt of approximately 5%. Pro forma year-end 2025, net leverage would have been 4.6x or approximately 3.2x with full synergy implementation. As mentioned earlier, one of our initial priorities for our free cash flow will be to deleverage. Beyond deleveraging, our cash flow will be an engine of shareholder value creation. First, maintenance capital. We expect to invest approximately $400 million per year on a combined basis to ensure safe and reliable operations. Second, the dividend. We expect to continue a stable dividend policy supported by resilient through-cycle cash flows of the combined company. With excess cash, we'll prioritize returning cash to shareholders and pursuing growth projects that meet a high return threshold. To summarize, this combination is a compelling opportunity for both sets of shareholders today and into the future. Together, Olin and Huntsman will create a greater than $12 billion North American chemicals leader that will better serve customers across diverse and growing end markets. The combination creates a vertically integrated platform with a structurally lower cost position. We'll approach integration with discipline, including how we segment and manage the combined company so that integrated manufacturing and downstream businesses can each succeed. OlinHuntsman will benefit from a highly experienced management team with a shared focus on value creation. This strategic combination creates greater resilience, stronger cash generation, and a balance sheet that will open multiple avenues to create value for our shareholders. With that, Chelsea, we're now ready to take questions. Thank you, sir. The floor is now open for questions. At this time, if you have a question or comment, please press star one on your telephone keypad. If at any point your question is answered, you may remove yourself from the queue by pressing star two. Please limit yourself to one question, and again, we ask that you pick up your handset when posing your questions to provide optimal sound quality. Our first question will come from Josh Spector with UBS. Please go ahead. Yeah. Hi, good morning. Thanks for taking my question. I guess I wanted to ask more on the Huntsman side specifically. It seems like doing this integration here, a lot of what Huntsman's been doing over the last decade has been shedding more of the commodity operations, kind of trying to focus more downstream. This seems like a step backwards in that regard. Obviously, the cost savings are large and are clearly a big driver here, but just curious strategically, why go this route now with the business versus what the strategy has been over the last 5, 10 years? Thanks. Josh, excellent question. As we look at our advanced materials and our ability to move further downstream, I see nothing in this merger that would in any way prohibit that. As a matter of fact, I see it as a great opportunity, that this will be an entity that will create even greater cash, create greater opportunity with a very resilient supply chain and a very competitive one at that. As I look at our competitors and the changing landscape around the world, the value that many of the people that we compete with today are integrated, whether it's in coal, in China or in the Middle East. Of subsidized or government-rationed gas or energy, or even in the U.S., being able to have a North American gas advantage. I look at all those regions around the world where we presently compete, we'll be in a more competitive position. We'll be in a company that is generating greater cash, has a stronger balance sheet. If anything, we'll have a greater opportunity to focus on those downstream applications. I see this as really a win-win on that strategy to keep us competitive. Thank you. Our next question will come from David Begleiter with Deutsche Bank. Please go ahead. Good morning. This is Emily Fusco on for Dave Begleiter. I was just wondering if you could maybe, for the $75 million purchasing economics, if there's any overlap on savings or just any color there? Hi, Emily. This is Ken. Listen, that $75 million is what we generate when we look at the joint purchases or the purchases that we do as independent companies, and you bring us together and you look at the price leverage that we'll have. We'll be reducing supplier bases. Those are pretty standard. We feel highly confident about achieving that $75 million. I would just note, Emily, that as we look at that $75 million, we've had our purchasing groups that have been able to interact and be able to pick, I wouldn't say that just the low-hanging fruit, but as you get these teams together, as you get better integrated, as you get operating and looking at the number of warehouses and transportation, logistics, all those areas that fall under purchasing, both Ken and I feel that these synergies are eminently doable, and if anything, once we get digging deeper, we think that there'll be even greater opportunity. Thank you. Our next question will come from Frank Mitsch with Fermium Research. Please go ahead. Good morning, gentlemen. Question for both Ken and Peter. Peter, you mentioned that you started in detail this combination four months ago. I'm curious from both of you as to what other options were considered and why was this one the best? Also, if you can enlighten us, is there a termination fee involved in this transaction? Thank you. Good morning, Frank. Thanks for joining us. Listen, as you can imagine, you know at least for Olin, we had an investor day back at the end of 2024, obviously when you go through and you do corporate strategy work, you look at other options. This is a clear strategic combination for us that always made a lot of sense. It's extremely compelling when you just look at the value chains where we participate and Huntsman participates. Very complementary. We always viewed this as one of the top of our priorities, I still feel that way today. We just were able to validate that over the last few months when we got our teams together. The amount of value that this creates is very significant. As I said in the prepared remarks, frankly, I do expect that we're going to be able to do this fairly quickly. If you look within two years, we will have achieved the majority of the $300 million, then there'll be another $100 million that we get in 2031. That is a lot of shareholder value that we're going to be creating with this combination. If you just capitalize those synergies, it's equivalent to about $2.5 billion-$3 billion. It's a big number. Frank, Peter here. I'm not sure there's another company in our industry that has gone through more large-scale potential transactions, divestitures, possible mergers, even outright sales. As I've said multiple times on earnings calls and in public audiences, I think that it's one of our first obligations as a company is to be able to look at our portfolio and to be able to ask some very serious questions about how that portfolio is best situated to create shareholder value. As I look at this merger of equals, I look at the synergies, I look at the management, look at the supply chains. This touches all three of our divisions. This isn't just an area that we're going to be bolstering epoxies or in polyurethanes. Every one of our divisions, the chlor-alkali chain is absolutely vital to our competitiveness. Being able to have a competitive, a resilient, and a global leader like Olin, being able to complement those downstream businesses. I think of all the opportunities that have been before us for years, this is really an ideal match for our company. Thank you. Our next question will come from Kevin McCarthy with Vertical Research Partners. Please go ahead. Yes, thank you very much. Two questions. On the synergy side, you have an additional $100 million of procurement savings in 2031. I was wondering if you could comment on why those particular savings would take longer to extract, or whether or not there are any contractual constraints at work there. Second, maybe for Ken, does this change strategic options as it relates to Winchester at all? Things like scale or tax angles associated with a theoretical separation there. I appreciate any thoughts on that subject. Absolutely. Thank you, Kevin. Listen, I'll start off with the easy one first. Yeah, that $100 million in 2031 is a synergy that is really related to timing of current contracts that will be expiring, and then Olin will step in and begin supplying that. That is a very easy one. That is a benefit that will happen. It's just a matter of time, and it'll be a very good fit with our portfolio. To your second question, Winchester is going to continue to be a very important part of our portfolio. It's going to continue to be run as a key business within OlinHuntsman. The strategy that we rolled out at the investor day at the end of 2024, where we said we were going to focus on growing our defense business and continuing to get a lot of value for the leading brand in the industry, that holds true. We see a lot of great things ahead for Winchester and nothing changes with that related to this combination. Thank you. Our next question will come from Jeff Zekauskas with JPMorgan. Please go ahead. Thanks very much. What are the cash costs of achieving the synergies? For Peter, Huntsman may have had the possibility of combining with an MDI producer. Why is it better over a longer period of time to not wait and look for an MDI opportunity rather than to merge in more of a diversification transaction? Jeff, excellent question. I think that as we look at the MDI industry, I think that you're probably limited to some degree with various antitrust issues on a global basis. More importantly than just MDI, which is certainly an important part of our company, but it is certainly not the entirety of our company. As we look at a transaction that is going to impact our downstream advanced materials, our amines, our MDI, really across the entire supply chain, this has a much greater impact on that than I think just adding more MDI tonnage. Being able to have a very competitive North American cost advantage, being able to have integration opportunity in Europe. I think that as we look at the growing markets in Asia for both companies, we see opportunities there to leverage existing contracts, existing customer relationships, and so forth. Yeah, I think there probably would be a space there for an expansion in MDI. As I look across the board again, across what is going to have the greatest impact for creating shareholder value across the board, this would have a much greater impact. Jeff, related to the cash cost of the synergies, that is $150 million-$200 million is what we're estimating. One thing that I want to point out as well is this is very consistent with the strategy that we've been laying out in terms of optionality for our ECUs. By doing this as a merger of equals, this doesn't take anything off the table. The options that we had before still remain, and I think as a combined company, they're going to be even as a stronger company when we're combined, those options are going to look even more attractive. Thank you. Our next question will come from Hassan Ahmed with Alembic Global Advisors. Please go ahead. Morning, Peter and Ken. I guess you guys mentioned that Winchester will continue to remain a core part of the portfolio. As you guys get more diversified in chemicals, I'm just trying to sort of understand if there are other portfolio management opportunities as well. Peter, historically you talked about growing the advanced materials business, but obviously, having more in the portfolio, could that be a divestiture candidate amongst others? No, I personally don't see that as a divestiture candidate. I see it as a continued platform for growth, both on the short term and on the longer term basis. As you think about supply chain, the resiliency, the uniqueness of this combination, being able to start with sodium chloride, with the salt molecule, take that all the way down, really uninterrupted, to the wing of a Boeing or Airbus jetliner. To be able to have that integration and to be able to look at the opportunities that exist within that chemistry along that entire, not just on the end, but also at the beginning of that chemistry, the efficiencies and so forth, the relationships that can be built, I think is terrific. No, I don't see that as a divestiture candidate. If anything, I see it as a core component to future organic growth. Thank you. Our next question will come from Laurence Alexander with Jefferies. Please go ahead. Good morning. It sounds as if you have significant strategic optionality in both the sort of ammunition defense and the epoxies and the MDI, potentially. How are you thinking about your balance sheet for the pro forma entity? How much would you be willing to flex the balance sheet for an acquisition? How would you think about an appropriate mid-cycle balance sheet target for the pro forma entity? Laurence, thank you for joining us. Listen, obviously, we're going to be doing a lot of work between now and closing to get ready for day one. There'll be a lot of work and thinking that we've got to do around strategy for OlinHuntsman. We, as I said just a minute ago, by structuring this as a merger of equals, we haven't really taken any options off the table. Now we've got to get together as OlinHuntsman and figure out where we want to go next. As we said in the prepared remarks, capital allocation, the priorities will continue to be, first, investing in our assets for safety and reliability, maintaining a stable dividend. Excess cash is going to go towards de-leveraging initially. That's got to be a priority for us in the short term. Beyond that, we're not ready to talk about any other strategic options. We're extremely excited about what the future holds. Yeah, I would just reemphasize what Ken said about that capital discipline. I think that's something where we are of one mind. The only thing that I see that is at all problematic with this merger is I wish it would've happened a year ago. Had we been in these challenging times that we're in today as an industry, and this merger had already taken place a year or two ago, the combined entity from a cash, from a balance sheet, from a resiliency point of view would be of that much greater value. I think I can speak for both of us saying that we're in these sort of market conditions, balance sheet strength and de-leveraging is going to be very key and fundamental. I hope that the time comes and we're generating the cash and so forth, and we have some great discussions internally as to where that cash should be deployed in other areas. Right now, particularly during these times, our focus is clear. Thank you. Our next question will come from Mike Harrison with Seaport Research Partners. Please go ahead. Hi. Good morning. Can you hear me okay? We can. Perfect. I'm just curious, from a revenue growth perspective, are there any end markets or geographic positions or maybe specific customers where Olin might be able to realize some cross-selling or other revenue synergies by leveraging Huntsman's presence or vice versa? To the extent that you see some revenue synergy opportunities out there, how should we think about the timing of realizing some of those synergies? Thank you. Good morning, Mike. Listen, one thing I want to be really clear about is we have not included any revenue synergies in these numbers. That doesn't mean that we don't see opportunities. We see a lot of opportunity, especially in the epoxy space, for us to be able to leverage the downstream business that Huntsman has with their channels, but also with the current Olin knowhow and backward integration. Bringing those two together is going to create a more competitive business that will allow us to be able to compete in some industries that maybe one of us weren't able to previously, and now we're going to be able to do that. There's a lot of opportunities that are still to come. I'm extremely optimistic that we will be able to grow not only current market positions, but enter new markets that maybe we haven't been able to in the past with the competitive position that we're going to have. Stay tuned. There's a lot more to come, but we have not included any of those revenue synergies so far in the valuation. Thank you. Our next question comes from Matthew Blair with Tudor, Pickering. Please go ahead. Thank you, and good morning. You highlighted the opportunities for cost cuts and integration benefits from the deal. I wanted to ask about valuation. These two companies tend to trade at pretty different multiples. I'm showing over the past three years that Huntsman has traded at an average forward consensus EBITDA multiple of nearly 10x. Olin is around 6.6x. My question is, as you were doing this analysis, where did you assume that the new co would trade? Is it a blended multiple, or is there a risk here that new co would trade at lower than a blended multiple, that it might be closer to the Olin multiple? Thank you. Matthew, I think that the market is going to have to determine that. When I look at the overall size resiliency, again, I don't want to get too much in the weeds here on multiple. Multiples have a lot to do with where you are at the cycle at any given point. If you're at the bottom of the cycle, you typically have a higher multiple, as you're at the top of the cycle, you're probably going to have a lower multiple. I think that as we look at this, rather than trying to get A multiple that's exactly right between the two. The market will determine if you have a more resilient company, if you have opportunities for growth, further synergies, further organic growth, efficiencies through your supply chain. As these things all come together, you see a stronger balance sheet is emerging, all of these things, I think, will have a factor into what your multiple is, that probably will be different than what Olin is today or what Huntsman is today. It'll be what OlinHuntsman's going to be. Absolutely. Matthew, just to reinforce, $2.5 billion-$3 billion of capitalized synergies is what our focus has been on and will continue to be on. Thank you. Our next question comes from Duffy Fischer with Goldman Sachs. Please go ahead. Yeah, good morning, fellas. Two questions. First one is just on a notional basis, how much does this integrate your ECU? If you basically sold everything from Olin to Huntsman, how many ECUs would you consume in doing that? Again, I don't think the exact number, but just roughly what is the integration? Yeah. Second, on the shares outstanding, if we just use your ratio in the 173 million from the last quarter, that'd be about 94.7 million shares. Is that the right number, or will there be some change of controlled stuff that there will actually be more shares involved with the conversion? Duffy, I'll take the first question. Then I'll ask Phil to comment on your second one. Listen, as you know, Olin is the largest chlor-alkali producer, this is a meaningful amount of integration for our ECUs. But as you know, we don't operate our assets fully loaded today in the trough that we're in. Yes, this is a great synergy, a great benefit for us as a combined company. But the optionality for our ECUs that we talked about at the end of 2024 are still intact. We're really excited about what we see here, probably as much from a downstream perspective as we do from an upstream. It's meaningful for us, but we still have got the largest footprint in chlor-alkali. Phil? Duffy, on the share count, the way the merger of equals will work is that you use a fully diluted share count. For Huntsman today, that's approximately 178 million shares. If you do the math on that with the exchange ratio that you quoted, you'll end up with 97 million shares, ultimately at conversion. Thank you. Our next question will come from John Roberts with Mizuho. Please go ahead. Thank you. Could you talk a little bit about the NOLs? Is the acceleration just the expectation of higher earnings post-merger, or is there something beyond that you're expecting? John, if you look at the merger and bringing both Huntsman and Olin together, and you look at the NOLs that Huntsman has, there's a clear opportunity to utilize those, particularly given the strength of Olin, and particularly given the strength of Olin in the United States, we would see a clear acceleration from bringing those two operations together. Thank you. Our last question will come from Bhavesh Lodaya with BMO Capital Markets. Please go ahead. Hi, good morning. Maybe a follow-up question on the balance sheet leverage. Do you see synergies as the primary way to delever the combined entity here? Then presumably with some initial costs around the merger, sort of integration, how should we think about the free cash flow profile in the initial years? Let me start, and then I'll let Phil comment as well. Listen, both the synergies and excess cash are going to be used to initially delever. I wouldn't say that one's primary over the other. We're going to work as hard as we can to realize the synergies as fast as we can. Todd Slater, I can promise you, is absolutely committed to doing that as quickly as possible. As we realize that and our earnings expand and our cash flow expands, we'll be allocating some of that cash to delever. Phil, what would you add to that? Yeah, if you look at the free cash flow delivery and just look back to 2025, a large focus from both teams on cash management. You look at the metrics around operating cash flow conversion, look at free cash flow conversion. Those have been pretty high for the company. That will remain as we go forward. It will be a stronger financial profile as a result of the delivery of those synergies, and that will fall through to the free cash flow line. We see a stronger free cash flow conversion as we move forward. Thank you. There are no further questions in the queue at this time. I'd like to turn the floor back over to Ken Lane, CEO of Olin, for any closing remarks. Thank you, Chelsea. We're very excited about our future as OlinHuntsman and the value we'll create. We look forward to continuing to engage with all of you as we progress toward closing the transaction. In the meantime, both Olin and Huntsman will continue to operate as two separate and independent companies. Our highly experienced management teams and thousands of associates and teammates around the world will continue to focus on safely and reliably serving our customers. We're grateful for all that they do each day to make Olin and Huntsman the incredible companies they are. Thank you all for joining us this morning. Thank you. This concludes today's conference call. Please disconnect your line at this time, and have a wonderful day.